[Osteoporosis in the genome era].
Osteoporosis is a disease based on the low bone mineral density causing the bone fragility. Among the heterogeneous pathophysiology of this disease, age-related decrease of bone mass plays a key role. Osteoporosis is recognized as a multifactorial disease to which genetic and life-style risk factors contribute. Recently, genetic factors have been studied with polymorphisms of genes related to bone metabolism. However, the results have not been consistent and the systemic genome-wide approach has been awaited. Genetic analysis of osteoporosis will be utilized for the efficient diagnostic tool and the development of new drugs.